It is easier to build strong children than to repair broken men.

~ Frederick Douglass

Book your appointment now!
Melbourne, FL | Vero Beach, FL | Massapequa, NY
& Global Tele-Health Services

Our Credentials

Join Us

img

Articles & News

By: Joann Amoroso-Pernice RDH, MAS™, QOM®

FDA Approves Zepbound (Tirzepatide) for Obstructive Sleep Apnea: A Revolutionary Treatment, But Not for Everyone

In a landmark move, the U.S. Food and Drug Administration (FDA) has approved Zepbound (tirzepatide) as the first-ever medication specifically for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults who also suffer from obesity. Manufactured by Eli Lilly, this approval marks a new era in OSA treatment, especially for patients who are unable to tolerate or adhere to traditional therapies like CPAP (Continuous Positive Airway Pressure). However, while this drug offers promising results, its side effects and potential risks mean that it may not be the right choice for everyone.... read more

26

Dec

By: CAFF Team

CAN SLEEP-DISORDERED BREATHING CAUSE DENTAL ISSUES?

Are your children snoring, awakening with dry mouth and headaches, and having trouble staying awake and focused during the day?... read more

24

Oct

By: Joann Amoroso RDH , MAS, QOM

The Potential of Tirzepatide in Treating Sleep Apnea: A Myofunctional Therapist’s Perspective

As we continue to explore and understand the full potential of new treatments, collaboration among healthcare providers remains crucial. By sharing knowledge and integrating various therapeutic approaches, we can offer our patients the best possible care and support.... read more

12

Jul

Airway is everything.
What is orofacial myofunctional therapy?

Watch The MyoAir Q&A